Bryant Lim Selected Research

neuronal pentraxin receptor

1/2020	Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.
1/2020	Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study.
11/2019	Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bryant Lim Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2018
2	Dementia (Dementias) 01/2020 - 01/2018
2	Cognitive Dysfunction 11/2019 - 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Disease Progression 11/2019
1	Amyloid Plaque 01/2018

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2018
3	neuronal pentraxin receptorIBA 01/2020 - 11/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	BenzodiazepinesIBA 01/2020
1	EnzymesIBA 11/2019
1	ImmunosorbentsIBA 11/2019
1	AutoantibodiesIBA 01/2019
1	Amyloid beta-PeptidesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	neuronal pentraxinIBA 01/2018